OmniaBio is pleased to share that our team will be attending the upcoming Meeting on the Mediterranean (MoM), April 28–30 , one of the leading international conferences for the cell and gene therapy community.

This year’s Meeting on the Mediterranean brings together global experts from academia, biopharma, and technology development to explore the latest advances in cell therapy manufacturing, translational science, and enabling technologies. The event provides a valuable forum for collaboration, knowledge‑sharing, and discussion around the future of advanced therapies.

While on site, the OmniaBio team will be connecting with partners and peers to discuss how our integrated CDMO capabilities support scalable, compliant manufacturing from cell banking through to clinical and commercial readiness.

If you’ll be attending the Meeting on the Mediterranean from April 28–30, we’d welcome the opportunity to connect.